Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Medtronic unveils VenaSeal Closure System in India to treat patients with CVD

      Medtronic unveils VenaSeal Closure System in India to treat patients with CVD

      Medical Dialogues Bureau27 July 2019 9:15 AM IST
      Mumbai: India Medtronic Private Limited, wholly-owned subsidiary of Medtronic plc, announced the launch of the VenaSeal Closure System, which is a...
      Patent Infringement: AstraZeneca moves US court against Dr Reddys on generic version of blockbuster Brilinta

      Patent Infringement: AstraZeneca moves US court against Dr Reddy's on generic version of blockbuster Brilinta

      Medical Dialogues Bureau26 July 2019 12:11 PM IST
      In a petition filed in the District Court of New Jersey on July 23, AstraZeneca alleged Dr Reddy's Lab's proposed generic Brilinta will infringe the...
      Cipla arm acquires anti-infective Zemdri from Achaogen to treat cUTI

      Cipla arm acquires anti-infective Zemdri from Achaogen to treat cUTI

      Medical Dialogues Bureau26 July 2019 9:45 AM IST
      Cipla USA has acquired worldwide rights of Zemdri, excluding Greater China, with its allied assets and limited liabilities, Cipla said in a late-night...
      Indoco Remedies gets USFDA warning letter for significant violations at Goa facility

      Indoco Remedies gets USFDA warning letter for significant violations at Goa facility

      Medical Dialogues Bureau26 July 2019 9:30 AM IST
      Stating the specific violations, the US Food and Drug Administration (USFDA) said Indoco Remedies failed to prepare batch production and control...
      Allergan announces worldwide recall of textured breast implant tied to rare cancer

      Allergan announces worldwide recall of textured breast implant tied to rare cancer

      Medical Dialogues Bureau26 July 2019 9:15 AM IST
      The U.S. Food and Drug Administration said it called for the removal after new information showed Allergan Inc's Biocell breast implants account for a...
      Zydus Cadila launches Ramelteon tablets in US to treat insomnia

      Zydus Cadila launches Ramelteon tablets in US to treat insomnia

      Medical Dialogues Bureau25 July 2019 11:23 AM IST
      In a BSE filing, Zydus Cadila announced the "launch of Ramelteon tablets, 8 mg upon receiving the final approval from the USFDA. Ramelteon is a...
      Manipal Group Stempeutics, Kemwell strike deal worth Rs 95 crore for global commercialisation of Stempeucel

      Manipal Group Stempeutics, Kemwell strike deal worth Rs 95 crore for global commercialisation of Stempeucel

      Medical Dialogues Bureau25 July 2019 9:45 AM IST
      The funds will be utilized for achieving key regulatory milestones in the US, Europe and Japan, and for establishing a cGMP cell therapy manufacturing...
      Syngene International Q1 net profit rises 9 percent to Rs 72 crore

      Syngene International Q1 net profit rises 9 percent to Rs 72 crore

      Medical Dialogues Bureau25 July 2019 9:30 AM IST
      The company had posted a net profit of Rs 66.2 crore for the same period previous fiscal, Syngene International said in a BSE filing.New Delhi:...
      Merck biosimilar to AbbVie blockbuster Humira wins USFDA approval

      Merck biosimilar to AbbVie blockbuster Humira wins USFDA approval

      Medical Dialogues Bureau25 July 2019 9:00 AM IST
      Humira is the world's best-selling prescription medicine and in the six years since AbbVie spun out from device maker Abbott Labs, the drug has...
      Pfizer gets USFDA nod for biosimilar to Rituximab

      Pfizer gets USFDA nod for biosimilar to Rituximab

      Medical Dialogues Bureau25 July 2019 8:59 AM IST
      Ruxience is a mAb biosimilar to Rituxan which works by targeting a protein called CD20, which is present on the surface of B cells. Ruxience is...
      NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

      NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

      Medical Dialogues Bureau24 July 2019 12:16 PM IST
      NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been...
      Alembic Pharma gets tentative USFDA nod for Dapagliflozin Tablets to improve glycemic control

      Alembic Pharma gets tentative USFDA nod for Dapagliflozin Tablets to improve glycemic control

      Medical Dialogues Bureau24 July 2019 10:00 AM IST
      The approved Dapagliflozin Tablets is therapeutically equivalent to the reference listed drug product Farxiga Tablets of AstraZeneca AB.New Delhi:...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok